Mostrando 2 resultados de: 2
Broadly neutralizing aptamers to SARS-CoV-2: A diverse panel of modified DNA antiviral agents
ArticleAbstract: Since its discovery, COVID-19 has rapidly spread across the globe and has had a massive toll on humaPalabras claves:aptamer, covid-19, modified DNA, MT: Oligonucleotides, SARS-COV-2, SELEX, Therapies and Applications, variants of concern, viral neutralizationAutores:Chadwick J., Chase C.N., Gelinas A.D., Harding A.C., James W.S., Janjic N., Javier Gilbert Jaramillo, Lee T., Liu S., Otis M.R., Ream B.E., Schneider D.J., Tan T.K., Zhang C.Fuentes:scopusIntranasal SARS-CoV-2 spike-based immunisation adjuvanted with polyethyleneimine elicits mucosal and systemic humoral responses in mice
ArticleAbstract: The SARS-CoV-2 pandemic continues despite the presence of effective vaccines, and novel vaccine apprPalabras claves:Adaptive immunity, covid-19, Mucosal adjuvant, RBD, SARS-COV-2, spike, VaccineAutores:Deimel L.P., James W.S., Javier Gilbert Jaramillo, Liu S., Liu X., Sattentau Q.J.Fuentes:scopus